Out of the Crisis #10: HelixNano founder Hannu Rajaniemi on vaccines, suspending disbelief, and the power of stories
Startup Lessons Learned
JUNE 24, 2020
HelixNano was founded to develop cancer vaccines. When co-founders Hannu Rajaniemi and Nikolai Eroshenko realized their work was applicable to a coronavirus vaccine, too, they changed direction immediately. It only took them a week to become fully committed to this new work. We have done this before for tools of war.
Let's personalize your content